ORIGINAL RESEARCH article
Front. Vet. Sci.
Sec. Parasitology
Volume 12 - 2025 | doi: 10.3389/fvets.2025.1547937
Development of multi-epitope Cathepsin L driven short peptide vaccine against Fasciola gigantica
Provisionally accepted
- Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Fasciolosis is an important zoonotic disease caused by Fasciola species (Fasciola spp.). Fasciola spp. infection has the potential to affect the livestock economy. Furthermore, liver flukes have been found to present Triclabendazole resistance in many countries. Vaccines are used to prevent fasciolosis and are currently considered the best alternative. However, no liver fluke vaccine is commercially available at present. Fasciola gigantica cathepsin Ls (FgCatLs) are vital enzymes for the liver fluke's survival. Therefore, this study aimed to design and investigate the immune response of multi-epitope Cathepsin L (MeCatL) driven short peptide vaccine for fasciolosis using immunoinformatic tools. FgCatLs sequences were predicted Linear B cell (BCL)-and Helper T lymphocyte (HTL)-specific immunogenic epitopes. The selected epitopes were marked on FgCatL's alignments. Novel epitopes were constructed from three criteria, including the selection process taking non-conserved host regions, overlapping FgCatLs sequences, and the highest percent conserved residues. Novel epitopes of BCL and HTL were linked with a linker to design a short peptide. MeCatL driven short peptide presented high antigenicity, non-allergenicity, non-toxicity, and good solubility. MeCatL driven short peptide was predicted and refined the tertiary structure. The refined MeCatL driven short peptide model indicated good quality structure that was investigated by Ramachandran plot, ERRAT, and Z-score. The refined MeCatL driven short peptide model interacted with Toll-like receptor 2 (TLR-2). The lowest energy was -1222.4 kJ/mol. The levels of IgM, IgG1, and IgG2 were increased in in silico immune simulation. MeCatL driven short peptide was synthesized and immunized in mice. IgG1 and IgG2a levels were increased after week 2, indicating IgG1 levels were dominating. MeCatL driven short peptide immunized sera can detect single proteins, including rFgCatL1, rFgCatL1G, and rFgCatL1H. In addition, MeCatL driven short peptide immunized sera was specifically detected in the cecal epithelium of NEJ and adult stages. These findings suggest that the MeCatL short peptide is a promising vaccine candidate, capable of inducing targeted immune responses, though further studies are needed to confirm its protective efficacy in vivo.
Keywords: Cathepsin L, Fasciola gigantica, Immunoinformatic, Multi-epitope, Peptide vaccine
Received: 18 Dec 2024; Accepted: 07 May 2025.
Copyright: © 2025 Chansap, Cheukamud, Suthisintong, Kueakhai and Changklungmoa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Narin Changklungmoa, Faculty of Allied Health Sciences, Burapha University, Chonburi, Thailand
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.